Literature DB >> 15743024

Presence of HPV in head and neck tumours: high prevalence in tonsillar localization.

A Venuti1, G Badaracco, C Rizzo, B Mafera, S Rahimi, M Vigili.   

Abstract

Human papillomavirus (HPV) seems to be involved in head and neck carcinogenesis. To investigate this association, viral presence and expression were analysed by polymerase chain reaction (PCR)-based methods and correlated to tumour localization, clinical-pathological aspects, and alcohol and tobacco exposure in 65 patients. HPV DNA was found in 16 cases (24.6%); the HPV types detected were: HPV16 (10 cases), HPV 6 (3 cases) HPV 33, 35, and 58 (one case each). The tonsil was the location with the highest HPV positivity (6/8, 75%). This percentage was significantly higher than that found in tumours from any other site (P<0.01). Viral transcripts of early regions were detected in all HPV16 positive tumours. HPV status was not related to age, gender, tumour stage or grade, and use of alcohol and/or tobacco. The results suggest that HPV16 is actively involved in the genesis of a subset of head and neck cancers and that the tonsillar localization may be considered a hot spot for viral transformation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15743024

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  27 in total

Review 1.  Vaccination against human papilloma virus (HPV): epidemiological evidence of HPV in non-genital cancers.

Authors:  Ioannis N Mammas; George Sourvinos; Apostolos Zaravinos; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2010-07-18       Impact factor: 3.201

2.  Immunotherapy in new pre-clinical models of HPV-associated oral cancers.

Authors:  Francesca Paolini; Silvia Massa; Isabella Manni; Rosella Franconi; Aldo Venuti
Journal:  Hum Vaccin Immunother       Date:  2013-01-07       Impact factor: 3.452

3.  Incidence of oral cavity and pharyngeal cancers by anatomical sites in population-based registries in Puerto Rico and the United States of America.

Authors:  Erick Suárez; Lorena González; Elba C Díaz-Toro; William A Calo; Francisco Bermúdez; Ana P Ortiz
Journal:  P R Health Sci J       Date:  2013-12       Impact factor: 0.705

Review 4.  Human papillomaviruses-related cancers. Presence and prevention strategies in the Middle east and north African regions.

Authors:  Ala-Eddin Al Moustafa; Rana Al-Awadhi; Nabiha Missaoui; Ishag Adam; Raika Durusoy; Lina Ghabreau; Nizar Akil; Hussain Gadelkarim Ahmed; Amber Yasmeen; Ghazi Alsbeih
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

5.  Case-matching analysis of head and neck squamous cell carcinoma in racial and ethnic minorities in the United States--possible role for human papillomavirus in survival disparities.

Authors:  Travis P Schrank; Yimei Han; Heidi Weiss; Vicente A Resto
Journal:  Head Neck       Date:  2011-01       Impact factor: 3.147

6.  Human papillomavirus infection and papillary squamous cell carcinoma in the head and neck region.

Authors:  Chao-Hui Yang; Chao-Cheng Huang; Ming-Tse Ko; Yu-Ching Wei; Chung-Feng Hwang
Journal:  Tumour Biol       Date:  2012-10-12

7.  Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7.

Authors:  David Lindquist; Mircea Romanitan; Lalle Hammarstedt; Anders Näsman; Hanna Dahlstrand; Johan Lindholm; Liselotte Onelöv; Torbjörn Ramqvist; Weimin Ye; Eva Munck-Wikland; Tina Dalianis
Journal:  Mol Oncol       Date:  2007-09-01       Impact factor: 6.603

8.  Concurrent radiotherapy plus epidermal growth factor receptor inhibitors in patients with human papillomavirus-related head and neck cancer.

Authors:  B Pajares; L Perez-Villa; J M Trigo; M D Toledo; M Alvarez; B Jimenez; J A Medina; V de Luque; J M Jerez; E Alba
Journal:  Clin Transl Oncol       Date:  2013-11-06       Impact factor: 3.405

9.  The co-presence of high-risk human papillomaviruses and Epstein-Barr virus is linked with tumor grade and stage in Qatari women with breast cancer.

Authors:  Ishita Gupta; Ayesha Jabeen; Reem Al-Sarraf; Hanan Farghaly; Semir Vranic; Ali A Sultan; Ala-Eddin Al Moustafa; Hamda Al-Thawadi
Journal:  Hum Vaccin Immunother       Date:  2020-10-02       Impact factor: 3.452

Review 10.  Progress and challenges in the vaccine-based treatment of head and neck cancers.

Authors:  Aldo Venuti
Journal:  J Exp Clin Cancer Res       Date:  2009-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.